Novel use of an FDA-approved BiVAD for total cardiopulmonary support

Journal of Cardiac Surgery

Volumn 18, Issue 5, 2003, Pages 411-414

  Kaplon, Richard J ^a   Nejman, Antoni ^a   Andreopoulos, Fotios ^a   Katariya, Kushagra ^a   Bolooki, Hooshang ^a   Kanevsky, Anatole ^a   Parpard, Michael ^a   Qi, Xiao ^a   Pham, Si M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ASSISTED CIRCULATION; CASE REPORT; DEVICE; EXTRACORPOREAL OXYGENATION; FOOD AND DRUG ADMINISTRATION; HEART TRANSPLANTATION; HUMAN; MALE; OXYGENATOR;

CORONARY DISEASE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; REOPERATION; RESPIRATORY INSUFFICIENCY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0141534256     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1540-8191.2003.02051.x     Document Type: Article

References (15)

1. Hill JD, Brien TG, Murray JJ, et al: Extracorporeal oxygenation for acute posttraumatic respiratory failure (shock-lung syndrome): use of the Bramson Membrane Lung. N Engl J Med 1972;286:629-634.
2. Hill JG, Bruhn PS, Cohen SE, et al: Emergent applications of cardiopulmonary support: a multiinstitutional experience. Ann Thorac Surg 1992;54:699-704.
3. Stolar CJH, Delosh T, Bartlett RH: Extracorporeal Life Support Organization 1993. ASAIO Trans 1993;39:976-979.
4. Magovern GJ, Magovern JA, Benckart DH, et al: Extracorporeal membrane oxygenation: preliminary results in patients with postcardiotomy cardiogenic shock. Ann Thorac Surg 1994;57(6):1462-1471.
5. Smedira NG, Moazami N, Golding CM, et al: Clinical experience with 202 adults receiving extracorporeal membrane oxygenation for cardiac failure: survival at five years. J Thorac Cardiovasc Surg 2001;122(1):92-102.
6. Pranikoff T, Hirschl RB, Steimle CN, et al: Efficacy of extracorporeal life support in the setting of adult cardiorespiratory failure. ASAIO J 1994;40(3):M339-M343.
7. Smedira NG, Wudel JH, Hlozek CC, et al: Venovenous extracorporeal life support for patients after cardiotomy. ASAIO J 1997;43:M444-M446.
8. Jett GK: Abiomed BVS 5000: experience and potential advantages. Ann Thorac Surg 1996;61(1):301-304.
9. Minami K, Posival H, el-Bynayosy A, et al: Mechanical ventricular support using pulsatile Abiomed BVS 5000 and centrifugal Biomedicus-pump in postcardiotomy shock. Int J Artif Organs 1994;17(9):492-428.
10. Kanter KR, McBride LR, Pennington DG, et al: Bridging to cardiac transplantation with pulsatile ventricular assist devices. Ann Thorac Surg 1988;46:134-140.
11. McCarthy PM, Smedira NG, Vargo RL, et al: One hundred patients with the Heartmate left ventricular assist device: evolving concepts and technology. J Thorac Cardiovasc Surg 1998;115:904-912.
12. Smedira NG, Massad MG, Navia JL, et al: Pulmonary hypertension is not a risk factor for RVAD use and death after left ventricular assist system. ASAIO J 1996;42:M733-M735.
13. Kormos RL, Gasior TA, Kawai A, et al: Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg 1996;111(4):773-782.
14. Dekkers RJ, Fitzgerald DJ, Couper GS: Five-year clinical experience with Abiomed BVS 5000 as a ventricular assist device for cardiac failure. Perfusion 2001;16(1):13-18.
15. Samuels LE, Holmes EC, Thomas MP, et al: Management of acute cardiac failure with mechanical assist: experience with the Abiomed BVS 5000. Ann Thorac Surg 2001;71(Suppl 3):S67-S72.